Project Grant K76AG088346
Award Date
9/1/24
Completion Date
5/31/29
Dollars Obligated
$243K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This $243,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to address critical knowledge gaps in the care of older adults with inflammatory bowel disease (IBD). The key objectives are to: (1) develop and validate a model to predict which older adults with IBD will require surgery, (2) derive a preoperative model to predict risk of major postoperative complications, including measures of sarcopenia, cognition, and...
This Project Grant award, valued at $231,000.00, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The funding supports research conducted by the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences), a non-profit research organization, to investigate the role of cyclic guanosine monophosphate (cGMP) signaling in intestinal aging. The primary objectives are to characterize cGMP signaling in the...
This $801,268 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Pittsburgh aims to develop innovative, scalable approaches to predict and prevent postoperative mortality, delirium, cognitive decline, and other complications in elderly surgical patients. The key objectives are to create robust preoperative risk prediction models and enable proactive multimodal interventions, including prehabilitation, to mitigate these serious...
This Project Grant award of $1,632,095 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development and use of a stochastic actor-oriented model (SAOM) to simulate workplace social network interventions for improving health behaviors in midlife adults. The research, conducted by The General Hospital Corporation (dba Massachusetts General Hospital), aims to identify optimal strategies for leveraging social connections to drive positive, equitable, and...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $192,851 provides funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop, refine, and pilot test an Alcohol Screening, Brief Intervention, and Referral to Treatment (A-SBIRT) protocol tailored for older adults with chronic pain. The goal is to create an affordable, scalable, and efficient intervention that can increase motivation...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a study to evaluate physical function, geriatric assessment tools, and biological aging markers as predictors of clinical and patient-reported outcomes in older adults with colorectal cancer. The $3,865,458 award, with an ultimate completion date of March 31, 2029, will fund a prospective cohort study of approximately 462 colorectal cancer patients aged 70 and above. The study will assess...
This $825,135 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the Massachusetts General Hospital to investigate the relationships between gut microbiome-related metabolites, cerebrovascular disease, Alzheimer's disease biomarkers, and cognitive impairment. The research will leverage data from the REGARDS and CARDIA longitudinal cohort studies to examine associations between gut microbiome metabolites, brain imaging markers, and the...
The National Institute on Aging (NIA) awarded a $243,000 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to Mayo Clinic to conduct research on assessing the needs and advancing dignity-conserving care for hospitalized, incarcerated older adults. The 5-year grant project will leverage a unique dataset to define trends in factors like age, delirium, and advance directive completion for this population. It will also use qualitative methods to characterize the...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a 5-year study to address the issue of potentially inappropriate medication (PIM) use among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The key objectives are to: 1) Identify factors and barriers/facilitators associated with routine PIM deprescribing practices for ADRD patients in home health care, using a mixed methods approach; and...
This Project Grant award of $561,600 from the National Institute on Aging's Aging Research program (CFDA 93.866) will support a project led by Dr. Matthew Growdon at the University of California, San Francisco. The project aims to characterize medication use and management supports among people with dementia who live alone, understand their medication-related experiences and needs, and develop a stakeholder-informed clinical decision framework to guide interventions for optimizing medication use...